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ABSTRACT

INTRODUCTION

The implications of high levels of the immune regulatory
cytokine IL-10 in Plasmodium falciparum malaria are unclear.
IL-10 may down-regulate pro-inflammatory responses and also
exacerbate disease by inhibiting anti-parasitic immune functions. To study possible inhibiting effects on parasite clearance,
IL-10 plasma levels were determined in 104 Tanzanian children, 1 to 4 years old, with acute uncomplicated P. falciparum
malaria, and analysed for association with parasite densities
during 3 days of anti-malarial treatment. Higher baseline
IL-10 plasma levels were associated with statistically significantly higher parasite densities after 24, 48 and 72 h of treatment. These associations could not be explained by differences
in initial parasitaemia, temperature, age, sex or type of treatment. Induction of high IL-10 production might be a direct or
indirect mechanism whereby the parasite evades the immune
response.

Work on murine experimental malaria suggests that a
non-lethal outcome of a malaria infection can, in part, be
explained by the ability of the mice to mount an early proinflammatory response, defined by IL-12, IFN-γ or TNF-α
production (1 – 3). TNF and IFN-γ act synergistically to
optimize nitric oxide (NO–) production, which is implicated
as an important factor in parasite killing (4). However, overproduction of IFN-γ and TNF-α predisposes to severe
pathology (5–7), suggesting that the ability to regulate the
pro-inflammatory responses is also crucial to survive the
infection. IL-10 is an anti-inflammatory cytokine which is
able to modulate immune responses to parasites in several
ways, including by inhibiting the production of IFN-γ and
IL-12. The clinical importance of IL-10 as a modulator of
the pro-inflammatory responses seen in human malaria is
however, yet to be defined. A low IL-10/TNF-α ratio, rather
than only high levels of TNF-α, is associated with malarial
anaemia (8–11). This suggests that anaemia might be promoted by high pro-inflammatory responses in the absence
of appropriate levels of anti-inflammatory factors. In severe
malaria, lower levels of plasma IL-12 and NO– combined
with higher IL-10 levels suggest that anti-parasitic responses
might be suppressed by high levels of anti-inflammatory
responses, resulting in severe disease (12,13).
The relationship between initial plasma levels of IL-10 and
parasite densities, determined daily during 3 days of treatment, was studied in 104 children with acute uncomplicated
Plasmodium falciparum malaria, with the hypothesis that
IL-10 inhibits anti-parasitic immune responses. The Tanzanian children, aged between 1 and 4 years, were admitted to
the hospital for a trial comparing four different anti-malaria
treatment regimes.
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METHODS
Study area and patients
Data and samples in this work were obtained from patients
included in a study designed to compare antipyretic, parasitological and immunological effects of four different antimalaria treatment regimes (14). The study was carried out
in Kibaha District Hospital 40 km north-west of Dar es
Salaam, Tanzania, an area holoendemic for malaria with
largely perennial transmission of mainly P. falciparum.
Children between 12 and 59 months of age attending the
primary health care unit of the hospital, between 3 July and
20 August 1998, were included in the study if they fulfilled
the inclusion criteria of uncomplicated mono-infection with
P. falciparum (2000 –250 000 parasites /µL, axillary temperature 37·5 – 40·0°C). Children were not eligible for the study
if they had severe malaria (as defined by altered level of
consciousness, convulsions, prostration, circulatory shock or
respiratory distress), hyperparasitaemia (> 250 000 parasites /
µL) or severe anaemia (haemoglobin level below 5·0 g/ dL).
Children with signs of coexisting diseases were also excluded.
The guardians of the children satisfying the inclusion
criteria were asked for their informed consent for the
children to be finally enrolled into the study. Ethical clearance
has been obtained from the Ministry of Health, Tanzania
and the Research Ethical committee of the Karolinska
Institutet, Stockholm, Sweden. The patients were admitted
to the hospital and treated with chloroquine phosphate alone
(F Hoffman-La Roche, Basel, Switzerland) once daily for
3 days, sulfadoxine / pyrimethamine (SP) alone (F HoffmanLa Roche, Basel, Switzerland) single dose, or SP + chloroquine or SP + paracetamol.

Sample collection
All children remained in the ward for 3 days. Axillary body
temperature was measured with a digital thermometer at
attendance to the primary health care unit of the hospital
and at the start of treatment (Time 0). Parasite species were
assessed by Giemsa-stained thin blood smears at admission,
and parasite densities by thick blood smears daily for 4 days.
The parasite densities were estimated by counting asexual
parasites per 200 leucocytes in the thick smear and expressed
as number of parasites per µL of blood, assuming an average
number of 8000 leucocytes per µL of blood. Blood samples
for cytokine determination were collected on day 0 (before
start of treatment), day 2 and day 3. The plasmas were
immediately separated by centrifugation and stored at −30°C
during the time of the study (at the most 2 months) and
thereafter stored at −70°C until transferred on dry ice
and stored at −70°C until analysed in the year 2000. Out of
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169 patients who participated in the study for 72 h, 104,
equally distributed between the four treatment groups, were
randomly selected for cytokine analyses.

Cytokine determination
Cytokine analyses were performed by a sandwich ELISA.
Half-area ELISA plates (Corning Incorporated, Corning,
NY, USA) were coated overnight at 4°C with 25 µL (1 µg/mL)
catcher α-IL-10 antibodies (9D7) (MABTECH, Stockholm,
Sweden). Phosphate buffered saline (PBS) supplemented
with 0·05% bovine serum albumin was used for blocking
(90 min, at RT) and for dilution of standards and plasma
samples. To ensure specific binding, blocking mouse
antibodies (1DIK) (MABTECH, Stockholm, Sweden) were
applied to the plates (20 µg/ mL, final concentration) immediately before samples and standards and incubated overnight at 4°C. The samples from each patient were coded and
distributed randomly in duplicates (diluted 1 : 1) in the plates.
Bound cytokines were assayed using biotinylated α-IL-10specific antibodies (12G8, 1 µg/ mL, 25 µL /well) (MABTECH,
Stockholm, Sweden) for 2 h at 37°C, followed by alkaline
phosphatase (ALP)-conjugated streptavidin (MABTECH,
Stockholm, Sweden) diluted 1 : 1000 and incubated (90 min, at
RT). Phosphatase substrate (Sigma Diagnostics, St Louis,
MO, USA) was applied and the optical density was read
at 450 nm. Cytokine concentrations were calculated from
standard curves obtained by incubating serial dilutions of
recombinant IL-10 (NIBSC, Hertfordshire, United Kingdom).
The standard was aliquoted and stored at −70°C.
The lower limit of detection, 30 pg/mL, was set according
to the linear part of the standard curve and the background
values of the buffer controls. The antibodies used for detection recognize both human and viral IL-10. TNF-α levels
were detected with the same procedure at the same time with
the antibodies Mab 1 and Mab 11 (Pharmingen, San Diego,
CA, USA).

Statistical analysis
The statistical package Stata was used for data analysis. The
associations of IL-10 levels (at time 0), with parasite densities at times 24, 48 and 72 h, were assessed using ordered
polytomous logistic regression. With this statistical method
it is possible to study the association between IL-10 levels
and parasite densities even with an increasing proportion of
the individuals with no parasites. Parasitaemia at time 0 was
loge (x + 1) transformed, and because this measure was normally distributed, it was modelled as a continuous variable.
This provided the finest grain adjustment possible in a
conditional change model. By ‘finest grain’ we mean that
adjustment for the baseline parasitaemia at zero hours uses
© 2004 Blackwell Publishing Ltd, Parasite Immunology, 26, 111–117
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the most precise measure possible and with greater precision
than the subsequent measures of parasitaemia used as dependent variables. This will ensure that reported associations
with parasitaemia are not artefacts of (perhaps subtle) differences at baseline parasitaemia. Models such as these are
known as conditional change models because the dependent
variable is conditioned on (adjusted for) an earlier measure
of the same factor.
Parasite densities at 48 and 72 h were not normally
distributed, even after log transformation. At all time points,
the measures were therefore converted into ordinal categorical variables to allow for comparable analysis for all outcome times. Parasite densities were categorized into fifths
of their distribution at 24 h, with an additional category for
those without any detected parasites. We used the distribution with the widest range of values (parasitaemia at 24 h)
to define the boundaries for our categories. If the distribution
at any of the other time points (48 or 72 h) had been used,
the results would have been substantially similar but the
measure would have been less sensitive. IL-10 and temperature were categorized into fifths of their distributions and age
was modelled in separate years (1–5). Simultaneous mutual
adjustment was made for: treatment, temperature at 0 h, IL10 at 0 h, parasite density at 0 h, age and sex. All variables
were modelled as series of binary dummies with the exception of parasite density at Time 0. Interaction of IL-10 with
treatment strategy was also tested. The interaction term
was included in the models with adjustment for baseline
parasitaemia and the other potentially confounding
factors as well as the main effects (IL-10 level and treatment
strategy).

RESULTS

Table 1 Distribution of the measures in 104 Tanzanian children
with P. falciparum

Categories
Parasitaemia 0 h
0
1 –1152
1153 – 2835
2836 – 8103
8104 – 22026
22027 – 200000
Parasitaemia 24 h
0
1 – 1152
1153 – 2835
2836 – 8103
8104 – 22026
22027 – 200000
Parasitaemia 48 h
0
1–1152
1153–2835
2836 –8103
8104 –22026
22027–200000
Parasitaemia 72 h
0
1–1152
1153–2835
2836 –8103
8104 –22026
22027–200000

Number
of patients

0
0
1
11
24
68
1
20
20
23
20
20
47
38
5
8
3
3
80
12
9
1
2
0

Categories
IL-10 0 h
0 –185·99
186 – 439·99
434 – 746·99
747 – 1699·99
1700 –15280
Temperature 0 h
37·4 – 37·8
37·9 – 38·2
38·3 – 38·4
38·5 – 38·7
38·8 – 40·1
Treatment
Chloroquine
SP
SP + Chloroquine
SP + Paracetamol
Age (months)
12
13 – 24
25 – 36
37 – 48
49 – 58
Sex
Male
Female
Total number

Number
of patients

21
20
20
22
21
19
24
16
21
24
25
26
26
27
8
37
36
17
6
56
48
104

Parasite density (parasites /µL) was divided into fifths of its
distribution at 24 h (24 h) and the same division was used for all time
points. IL-10 and temperature values are categorized according to
plasma levels (pg /mL) or degrees Celsius (°C) at time 0 h. Each age
category represents 1 year of age. SP = Sulfadoxine-Pyrimethamine.

Data distribution
Plasma levels of IL-10 were detectable in all 104 patients
and categorized as shown in Table 1. The distribution of
parasite densities at 24 h was categorized by division into
fifths. The same cut-points for parasitaemia were used when
categorizing the distribution at 48 and 72 h (Table 1), for
continuity between the three sets of models.

IL-10 levels at 0 h and subsequent parasite densities
Tables 2 – 4 show odds ratios for parasite density associated
with IL-10 level at time 0 h. A higher odds ratio indicates a
higher likelihood of greater parasite density in an IL-10
category compared with the reference.
Higher concentrations of IL-10 at time 0 were associated
with subsequently higher parasite densities at 24, 48 and
72 h of treatment (Tables 2– 4 and Figure 1) independently of
© 2004 Blackwell Publishing Ltd, Parasite Immunology, 26, 111–117

initial parasitaemia. Since the patients were treated with four
different treatment regimes, adjustment was consistently made
for this factor. Categorical and continuous log-transformed
measures of initial parasitaemia were compared, in the
same model, for the strongest association with parasitaemia
at 24, 48 and 72 h. The continuous variable presented the
finest-grain adjustment (data not shown) and was therefore
used (in columns 2 and 3). In the final model (column 3),
adjustments were made for several potential confounding
factors: treatment, initial parasitaemia, temperature, age and
sex. At 24 h (Table 2), the association increased between
each succeeding category of IL-10 and was statistically significant for the categories with the two highest IL-10 levels
compared to the lowest. At 48 and 72 h, the levels went up
until the second highest category of IL-10 and then reached
a plateau (Tables 3 and 4). These associations were independent
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Table 2 Plasma levels of IL-10 and the risk of higher parasite densities after 24 h of treatment
Odds ratioa

Odds ratiob

IL-10 (pg/mL)

Odds

95% CI

P-value

Odds

0– 185·99
186–439·99
434–746·99
747–1699·99
1700–15280

1·00
1·05
2·58
2·95
29·21

Reference
(0·34 – 3·27)
(0·83 – 8·05)
(0·98 – 8·86)
(8·07 – 105·82)

0·93
0·10
0·05
0·00

1·00
1·65
2·93
2·66
37·78

Odds ratioc

95% CI
Reference
(0·51 – 5·33)
(0·93 – 9·23)
(0·88 – 8·05)
(9·90 – 144·20)

P-value

Odds

95% CI

P-value

0·40
0·07
0·08
0·00

1·00
2·37
3·76
4·44
69·89

Reference
(0·61 – 9·25)
(1·00 – 14·15)
(1·26 – 15·66)
(13·47 – 362·68)

0·21
0·05
0·02
0·00

The odds ratios estimate risk of higher parasite density and were generated using ordered polytomous logistic regression.
Adjustments were made for the variables: atreatment, btreatment and continuous log parasitaemia at time 0, ctreatment, continuous log
parasitaemia at time 0, age, sex and temperature at time 0.

Table 3 Plasma levels of IL-10 and the risk of higher parasite densities after 48 h of treatment
Odds ratioa

Odds ratiob

IL-10 (pg/ml)

Odds

95% CI

P-value

Odds

0– 185·99
186–439·99
434–746·99
747–1699·99
1700–15280

1·00
0·84
2·51
4·81
3·15

Reference
(0·21 – 3·29)
(0·68 – 9·27)
(1·34 – 17·22)
(0·86 – 11·54)

0·80
0·17
0·02
0·08

1·00
1·15
2·78
4·36
2·99

Odds ratioc

95% CI
Reference
(0·28 – 4·71)
(0·75 – 10·38)
(1·21 – 15·71)
(0·81 – 11·09)

P-value

Odds

95% CI

P-value

0·85
0·13
0·02
0·10

1·00
1·12
2·92
4·24
2·50

Reference
(0·24 – 5·16)
(0·66 – 12·94)
(1·05 – 17·12)
(0·55 – 11·42)

0·88
0·16
0·04
0·24

The odds ratios estimate risk of higher parasite density and were generated using ordered polytomous logistic regression.
Adjustments were made for the variables: atreatment, btreatment and continuous log parasitaemia at time 0, ctreatment, continuous log
parasitaemia at time 0, age, sex and temperature at time 0.

Table 4 Plasma levels of IL-10 and the risk of higher parasite densities after 72 h of treatment
Odds ratioa

Odds ratiob

Odds ratioc

IL-10 (pg/mL)

Odds

95% CI

P-value

Odds

95% CI

P-value

Odds

95% CI

P-value

0– 185·99
186–439·99
434–746·99
747–1699·99
1700–15280

1·00
1·34
4·43
10·90
8·38

Reference
(0·17 – 10·51)
(0·51 – 38·38)
(1·67 – 71·33)
(1·22 – 57·46)

0·78
0·18
0·01
0·03

1·00
1·83
5·11
10·01
8·35

Reference
(0·28 – 4·71)
(0·75 – 10·38)
(1·21 – 15·71)
(0·81 – 11·09)

0·58
0·14
0·02
0·03

1·00
3·85
13·72
16·72
15·64

Reference
(0·32 – 45·69)
(0·95 – 198·78)
(1·68 – 165·93)
(1·32 – 184·89)

0·28
0·05
0·02
0·03

The odds ratios estimate risk of higher parasite density and were generated using ordered polytomous logistic regression.
Adjustments were made for the variables: atreatment, btreatment and continuous log parasitaemia at time 0, ctreatment, continuous log
parasitaemia at time 0, age, sex and temperature at time 0.

of all the potential confounding factors, even the finergrain measure of parasite density at 0 h. IL-10 level was predictive of parasite densities in all treatment arms and there
was no significant interaction of treatment strategy with
IL-10 level (P > 0·05) with regard to subsequent parasitaemia after adjustment for the main effects.
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The median plasma level of IL-10 decreased during the
treatment period, from the level at 0 h: 503 (lower and upper
quartile: (238–1479)) pg/mL to 198 (55–483) and 124 (44–
238) pg/mL at 48 and 72 h, respectively. The median levels
of IL-10 at 48 and 72 h were generally higher in the groups
with the higher baseline levels of IL-10 (Figure 2).
© 2004 Blackwell Publishing Ltd, Parasite Immunology, 26, 111–117

IL-10 levels and clearance of P. falciparum

Volume 26, Number 3, March 2004

Figure 2 Medians of plasma IL-10 levels during treatment. The
children were divided into five consecutive groups, with increasing
baseline levels of IL-10. Category boundaries for IL-10 levels are
shown in Table 1.

quarters of the detectable distribution. When compared by
testing trends across the categories, there was no notable or
statistically significant association between TNF-α concentration and parasitaemia (data not shown).

DISCUSSION

Figure 1 Odds ratios and 95% confidence intervals for higher
parasite densities at (a) 24, (b) 48 and (c) 72 h by IL-10 levels at 0 h
were generated using ordered polytomous logistic regression.
Simultaneous adjustment was made for continuous log parasitaemia
at 0 h, age, sex, treatment and temperature. Category boundaries
for IL-10 levels are shown in Table 1.

To test the association of TNF-α with parasitaemia, the
measure of TNF-α was divided into five ordinal categories,
the first representing subjects with levels below the detectable threshold and the other four representing equally sized
© 2004 Blackwell Publishing Ltd, Parasite Immunology, 26, 111–117

A positive association between serum IL-10 level and parasite density in symptomatic P. falciparum malaria (before
start of treatment) has been described previously (13). The
consequences of the presence of IL-10 for parasite killing
are however, not known. We found associations between
initial IL-10 levels and parasite densities during treatment,
indicating that the IL-10 levels may play a role in the clearance of parasites during treatment. Since the IL-10 level is
associated with the initial parasite burden, there is a risk
that an association between IL-10 and parasite clearance
may only reflect the situation that those with high parasitaemia at the start had more parasites throughout the treatment.
Therefore we used a statistical model where the outcome was
conditional on the initial parasitaemia (15). Such adjustment
even enhanced the association between IL-10 level and the
risk of having higher parasite density at 24 h. This implies
that IL-10 may be a better indicator of the parasiticidal
efficacy during the first day of treatment than the initial
parasitaemia. This was not an artefact due to a more precise
measure of the distribution of IL-10 compared with initial
parasitaemia in our modelling, since we used the most precise
measure of the parasite distribution at day 0. By adjusting
for temperature, treatment, age and sex we found that the
associations were also independent of these potential confounding factors.

115

E. Hugosson et al.

Contrary to our results, Luty et al. found a negative association between parasite clearance time and in vitro induction
of IL-10 production in malaria antigen stimulated PBMCs
from Gabonese patients with acute P. falciparum infection (16).
Their study investigated whether the donors responded with
or without IL-10 production, indicating the need of P. falciparum antigen-specific cells to obtain faster clearance of
parasites during treatment. In contrast, all our patients produced
IL-10 and we focused on the relevance of the magnitude
of production. The apparent difference in frequency of IL-10
detection is probably caused by the use of different methods.
One limitation of measuring cytokine levels in plasma or
supernatants is that the bioactivity of the cytokine may be
poorly correlated with the protein level. Additionally, cytokine
detection after in vitro stimulation of cells in culture may
reflect conditions that are not relevant to the in vivo situation. Theoretically, re-stimulation of cells already activated
in vivo, may lead to in vitro apoptosis or anergy, which may
underestimate the production of that cytokine in vivo. Few
studies have compared serum and ex vivo induced cytokine
production during infectious diseases but those generally
show inconsistent results using these different techniques
(9,17–19). Other limitations in human studies are difficulties
in measuring immune reactions in tissue or immune organs,
apart from the peripheral blood. However, for blood stages
of malaria the peripheral blood should be a relevant immune
organ for studies of systemic regulatory molecules like
IL-10. Consistent with this assumption, several studies have
shown strong correlation between serum levels of IL-10 and
clinical manifestations (13,20). The levels of IL-10 detected
here were within the range detected in similar studies: they
were higher than some (10) and lower than others (8,21).
The efficacy of anti-malarial drugs on parasite clearance
depends on the sensitivity of the parasite, the drug levels
over time and the immune defence (22). In our study the
patients were treated with four different drug regimens with
different parasite clearance rates (14). Type of treatment did
not affect our results, since IL-10 was predictive of parasite
clearance in all treatment arms and there was no interaction
between IL-10 level and treatment arm. Our study thus
identified a general association between IL-10 level and
reduced parasite clearance irrespective of treatment. This
does not necessarily imply a similar negative effect on parasite clearance in untreated malaria.
The drop in IL-10 levels over the study period implies that
the IL-10 production is affected by the treatment, the reduction in parasite load or other disease causing factors. The
cause–effect relationship between these variables could not
be identified with our model but would be interesting to
address in future studies.
Since the mechanism (s) of parasite killing has not been
fully described, we can only speculate how IL-10 may influ-
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ence parasite clearance. IL-10 is an important immune
modulating factor executing anti-inflammatory activities by
inhibiting activation of antigen-presenting cells (APC), reducing their ability to induce T cell responses (23). IL-10 inhibits
APC production of cytokines and effector molecules like
NO– (23). Stimulation of T cells in the presence of IL-10 is
also thought to promote induction of regulatory T cells,
which become tolerant or unresponsive to the stimulating
antigen (24,25). The inhibitory effects seen for IL-10 on
parasite killing could operate at any of these levels. NO– and
reactive oxygen intermediates have been proposed as possible effector molecules in malaria parasite killing (4,26,27)
and data suggest an association between increased levels of
these molecules and shorter parasite clearance time (22,28).
High IL-10 levels might thus aggravate the disease by downregulating the production of these molecules directly or via
down-regulation of pro-inflammatory cytokines. In support
of this, other reports show lower levels of plasma IL-12 or
NO– in combination with higher IL-10 and TNF levels in
more severe forms of malaria (12,13). Studying ratios between
pro- and anti-inflammatory cytokines for the prognostic
of parasite killing might add more information of what
cytokine profiles are beneficial or detrimental (29). In this
way it was identified that hyperparasitaemia in children was
associated with higher ratios of IL-10 : TNF plasma levels
(11). We could not study ratios between IL-10 and TNF-α
here because of insufficiently sensitivity of the TNF-α detection, but this would be worth trying in future studies. Hence,
we found no univeriate association between TNF-α and
parasitaemia, nor between TNF-α and any of the parasite
categories.
The parasite might ‘deliberately’ enhance the IL-10 production in order to interfere with the balance between proand anti-inflammatory immune reactions to escape effective
parasite killing. There is in vitro evidence that falciparuminfected erythrocytes increase the secretion of IL-10 and
reduce the secretion of IL-12 during maturation of dendritic
cells (30,31). These effects on DC were similar to what was
found when the cells were exposed to apoptotic cells or
ligation of CD36 and/or CD51. Such mechanisms might be
overcome after repeated infections, since neither high levels
of IL-10 nor particular pro-inflammatory responses are found
in children in endemic areas with significant numbers of
parasites but without clinical symptoms (21).
Differences in the magnitude of IL-10 production may
reflect differences in host characteristics, including genetic
differences, semi-immunity, co-infections or nutritional status
and possibly differences in parasite strains. In any event,
our data suggest that higher IL-10 levels are associated with
poorer subsequent parasite clearance. Thus, IL-10 levels may
represent a useful prognostic marker in identifying patients
who are more susceptible to slower parasite clearance.
© 2004 Blackwell Publishing Ltd, Parasite Immunology, 26, 111–117
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